Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L.
Sacco, M.D., Ma, C., Lagarias, P., Gao, A., Townsend, J.A., Meng, X., Dube, P., Zhang, X., Hu, Y., Kitamura, N., Hurst, B., Tarbet, B., Marty, M.T., Kolocouris, A., Xiang, Y., Chen, Y., Wang, J.(2020) Sci Adv 6
- PubMed: 33158912 
- DOI: 10.1126/sciadv.abe0751
- Primary Citation of Related Structures:  
6XA4, 6XBG, 6XBH, 6XBI, 6XFN - PubMed Abstract: 
The main protease (M pro ) of SARS-CoV-2 is a key antiviral drug target. While most M pro inhibitors have a γ-lactam glutamine surrogate at the P1 position, we recently found that several M pro inhibitors have hydrophobic moieties at the P1 site, including calpain inhibitors II and XII, which are also active against human cathepsin L, a host protease that is important for viral entry ...